Global Health NOW [13 June, 2017]
“Tapping student potential: Q&A on DNDi’s Open Synthesis Network with Ben Perry”
by Rahman R, Goyal V, Haque R, Jamil K, Faiz A, Samad R, Ellis S, Balasegaram M, den Boer M, Rijal S, Strub-Wourgaft N, Alves F, Alvar J, Sharma B.
PLOS Neglected Tropical Diseases, June 2017
by Ibarra-Meneses AV, Ghosh P, Hossain P, Chowdhury R, Mondal D, Alvar J, Moreno J and Carrillo E.
Frontiers in Cellular and Infection Microbiology, May 2017
by Thompson A, O’Connor PD, Marshall AJ, Yardley V, Maes L, Gupta S, Launay D, Braillard S, Chatelain E, Franzblau SG, Wan B, Wang Y, Ma Z, Cooper CB, Denny WA.
Journal of Medicinal Chemistry, May 2017
November 5-9, 2017
Baltimore, Maryland, USA
DNDi took part in symposia, poster and oral presentation sessions at the meeting.
by Molina R, Ghosh D, Carrillo E, Monnerat S, Bern C, Mondal D, Alvar J.
Clinical Infectious Diseases, May 2017
El Periódico [22 May, 2017]
“El MNCN presenta una exposición sobre la leishmaniasis, que cada año ataca un millón de personas” – “The MNCN held an exhibition on leishmaniasis, a disease which attacks one million people every year”
Granada Hoy [20 May, 2017]
“La leishmaniasis, una enfermedad olvidada pero que aún persiste” – “Leishmaniasis, a disease that is forgotten but still persists”
The Guardian [18 May, 2017]
“Hope in battle against ‘deadliest disease you’ve never heard of'”
Chemical & Engineering News [15 May, 2017]
“Students seeking drug leads for visceral leishmaniasis”
El País [3 May, 2017]
“El remedio que se busca en plantas y ordenadores” – “The remedy sought in plants and computers”
[London and New York – May 3, 2017]
Indian, UK and US students to help discover desperately-needed drug leads for visceral leishmaniasis
The non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) has launched a collaborative project with five universities in India, the UK, and the US to harness the capacity of university teaching laboratories and task students with discovering potential new drugs for patients living with neglected diseases.